Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Synamics Therapeutics is a biotechnology company focused on drug discovery by anticipating disease evolution. Their proprietary platform, Dynaptive™, is designed to predict how diseases will change…

Synamics Therapeutics is a biotechnology company focused on drug discovery by anticipating disease evolution. Their proprietary platform, Dynaptive™, is designed to predict how diseases will change…
What they do: AI-driven biotech using an evolution-aware platform (Dynaptive) for drug discovery
Founded: 2023
Headquarters: San Francisco, California, United States
Stage / Size: Private, Pre-Seed; headcount reported 1–10
Investor signals: Early backing from Plug and Play, Per Falholt, Steen Riisgaard
Reducing drug development failures by accounting for disease evolution in therapeutic design.
2023
Biotechnology
Listed as a Pre-Seed round on external profiles; amount not disclosed in provided evidence.
Most-recent round date reported as May 9, 2025; amount obfuscated in cited profiles.
“Early backing from Plug and Play, Per Falholt, Steen Riisgaard”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
4,300+
New This Week